pH‐Responsive Isoprenoid‐Antitumoral Polymer Conjugates for Superior Drug Loading via Self‐Assembly and Endosomal‐Targeted Anticancer Activity
Open Access
- 31 January 2026
- journal article
- Published by Wiley in ChemMedChem
- Vol. 21 (2) , e202500810
Abstract
Polymer‐drug conjugates (PDCs) are a promising strategy to enhance the delivery of poorly soluble drugs, particularly in cancer therapy. By improving solubility and enabling site‐specific accumulation, PDCs minimize systemic toxicity while maximizing therapeutic efficacy. PDCs often employ stimuli‐responsive linkers, such as Schiff's bases, to achieve controlled drug release in tumor microenvironments or acidic intracellular compartments. In this study, we designed a novel PDC by conjugating the anticancer agent farnesal (Far) to ∈‐Poly‐L‐Lysine (PL) via an imine bond, without using additional linkers. PL is a natural, biodegradable, water‐soluble polymer with inherent anticancer properties, while Far is a hydrophobic isoprenoid with potent antitumor activity. The conjugate (Far‐PL) displayed pH‐responsive behavior, remaining stable at physiological pH but releasing drugs under acidic tumor (pH 6.5) and endosomal (pH 5.5) conditions. Far‐PL exhibited enhanced cytotoxicity against A549 lung cancer cells compared to its components alone, while showing reduced toxicity towards noncancerous cells (Arlo cells). The amphiphilicity allows the conjugate to self‐assemble into stable nanoparticles with a positive surface charge, narrow size distribution, and 100% drug content—clearly exceeding conventional nanoparticles (5–10 wt%). This effective PDC design demonstrates strong potential to maximize tumor‐selective activity while minimizing off‐target effects, offering a promising platform for future cancer therapeutics.Keywords
This publication has 103 references indexed in Scilit:
- Enhanced apoptosis through farnesol inhibition of phospholipase D signal transductionThe FEBS Journal, 2005
- Up-regulation of c-Jun-NH2-kinase pathway contributes to the induction of mitochondria-mediated apoptosis by α-tocopheryl succinate in human prostate cancer cellsMolecular Cancer Therapeutics, 2005
- Studies of the Isoprenoid-Mediated Inhibition of Mevalonate Synthesis Applied to Cancer Chemotherapy and ChemopreventionExperimental Biology and Medicine, 2004
- Nanosuspensions: a promising drug delivery strategyJournal of Pharmacy and Pharmacology, 2004
- Black tea protects immunocytes from tumor-induced apoptosis by changing Bcl-2/Bax ratioCancer Letters, 2004
- Physico-chemical stability of colloidal lipid particlesBiomaterials, 2003
- Responsive polymeric delivery systemsAdvanced Drug Delivery Reviews, 2001
- VEGF Receptor Signaling in Tumor AngiogenesisThe Oncologist, 2000
- Competitive Inhibition of Choline Phosphotransferase by Geranylgeraniol and Farnesol Inhibits Phosphatidylcholine Synthesis and Induces Apoptosis in Human Lung Adenocarcinoma A549 CellsJournal of Biological Chemistry, 1998
- Farnesol and Geranylgeraniol Induce Actin Cytoskeleton Disorganization and Apoptosis in A549 Lung Adenocarcinoma CellsBiochemical and Biophysical Research Communications, 1996